We are honored to announce that Mary Mullins is the recipient of the CNV 2023 Award. The Christiane Nüsslein-Volhard Award honors the outstanding... Read More
A team of researchers including Nico Plachta, PhD, have a great new paper on early human preimplantation development that is... Read More
It is with great sadness that we acknowledge the loss of our friend, Dr. Frank A. Pepe, Professor Emeritus in... Read More
Congratulations Raj!... Read More
Congratulations, Celeste!... Read More
Domingo-Muelas A, Skory RM, Moverley AA, Ardestani G, Pomp O, Rubio C, Tetlak P, Hernandez B, Rhon-Calderon EA, Navarro-Sánchez L,... Read More
Skory RM, Moverley AA, Ardestani G, Alvarez Y, Domingo-Muelas A, Pomp O, Hernandez B, Tetlak P, Bissiere S, Stern CD,... Read More
Amelie A Raz, Gabriela S Vida, Sarah R Stern, Sharvani Mahadevaraju, Jaclyn M Fingerhut, Jennifer M Viveiros, Soumitra Pal, Jasmine... Read More
Leonard EV, Hasan SS, Siekmann AF. Temporally and regionally distinct morphogenetic processes govern zebrafish caudal fin blood vessel network expansion.... Read More
Lorenzo, D.N., Edwards, R.J. & Slavutsky, A.L. Spectrins: molecular organizers and targets of neurological disorders. Nat Rev Neurosci 24, 195–212... Read More
Shelly Berger is studying how genes are turned on and off in the brain, and how different patterns of gene activation could be related to Alzheimer’s disease.
Research led by by Raffaella Nativio, former research associate in the Berger Lab, Shelley Berger, Daniel S Och Professor and director of the Epigenetics Institute,
An experimental study from researchers in the Perelman School of Medicine at the University of Pennsylvania links a specific procedure – embryo culture – that is part of the assisted reproduction process (ART) to placental abnormalities,
“Senotherapy,” a treatment that uses small molecule drugs to target “senescent” cells, or those cells that no longer undergo cell division,
Penn study uncovers key mechanisms behind embryonic development, moving the regenerative medicine field closer to developing cell therapies. You can find the Penn Medicine News Release here.